Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Higher sales of daily-delivery food products and products for hospitals and nursing care facilities compared with the previous fiscal year, as well as the implementation of price revisions, among other factors.
Not applicable (no matters requiring disclosure under the going concern assumption)
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥57,492 million (YoY +2.9%) |
| Operating profit | ¥647 million (YoY +12.7%) |
| Ordinary income | ¥686 million (YoY +34.4%) |
| Profit attributable to owners of the parent | ¥514 million (YoY +33.7%) |
| Net income per share | ¥42.53 |
| Operating Margin | 1.1% (1.0% in the previous fiscal year) |
| Equity ratio | End of the current fiscal period 40.6％ / End of previous period 40.3％ |
| Total assets | ¥41,201 million |
| Net assets | ¥17,277 million |
| Cash flows from operating activities | ¥2,735 million |
| Cash flows from investing activities | ¥-1,348 million |
| Cash flows from financing activities | ¥-595 million |
| Cash and cash equivalents at end of period | ¥4,279 million |
| Full-year earnings forecast | Net Sales ¥60,000 million (YoY +4.4%) / Operating profit ¥800 million (YoY +23.6%) / Ordinary income ¥800 million (YoY +16.6%) / Profit attributable to owners of the parent ¥400 million (YoY -22.3%) |
| Annual Dividend Forecast | ¥12 → ¥12（0.0%） |
| Payout ratio | 28.2% (fiscal year ending March 2026), 36.3% (forecast for fiscal year ending March 2027) |
| Depreciation and amortization | ¥1,673,722 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥111 thousand, Gain on sale of investment securities ¥87,193 thousand / Extraordinary loss Loss on Disposal of Fixed Assets ¥22,964 thousand |
| Disclosure regarding the going concern assumption | Not applicable (no matters requiring disclosure under the going concern assumption) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社シロッコさがえ / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 12,102,660 Shares |
| Treasury Shares at Period-End | 4,815 Shares |
| Factors Behind Changes in Business Performance | Higher sales of daily-delivery food products and products for hospitals and nursing care facilities compared with the previous fiscal year, as well as the implementation of price revisions, among other factors. |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase in net sales for the fiscal year was attributed to higher sales of daily-delivery food products and products for hospitals and nursing care facilities compared with the previous fiscal year, as well as the implementation of price revisions. For the next fiscal year, the Company plans to strengthen its quality assurance framework, product development, sales activities and cost reduction initiatives.